Discover
VNRX
VolitionRx Limited
1.36
300 x undefined
7000 x 1.35
bid
ask
+
0.01
0.74%
3650 @ 06:12 AM
1.33 -0.03 (2.21%)
| Ytd | -73.85% | |
| 1y | -91.17% |
1.33
day range
1.41
1.17
52 week range
16.40
| Open | 1.36 | Prev Close | 1.35 | Low | 1.33 | High | 1.41 | Mkt Cap | 16.21M |
| Vol | 200.81K | Avg Vol | 285.36K | EPS | -4.25 | P/E | N/A | Forward P/E | -3.83 |
| Beta | 1.10 | Short Ratio | 3.71 | Inst. Own | 19.11% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-13 | 50-d Avg | 2.13 | 200-d Avg | 5.40 | 1yr Est | 3.34 |
VNRX News
benzinga.com
VolitionRx Partners With Sysmex To Streamline Volition's Nu.Q NETs H3.1 Assay
VolitionRx Limited (NYSE:VNRX) ("Volition"), a multi-national epigenetics company, announces
benzinga.com
12 Health Care Stocks Moving In Thursday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Tuesday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Monday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Monday's Pre-Market Session
benzinga.com
U.S. State Dept Announces Nearly $38M In Additional Funding Toward The Department's Ongoing Ebola Re
https://www.state.gov/releases/office-of-the-spokesperson/2026/06/ebola-response-update-june-5-2026/